Lamers W H, Zonneveld D, Charles R
Dev Biol. 1984 Oct;105(2):500-8. doi: 10.1016/0012-1606(84)90307-5.
Glucocorticosteroids and cyclic AMP induce carbamoylphosphate synthetase (ammonia) (CPS) in rat hepatocytes. Using an enzyme immunoassay applied to hepatocyte cultures fixed in situ, it has been demonstrated that the capacity of hepatocytes to synthesize CPS in the presence of both hormones is present as soon as the cells become recognizable as hepatocytes. Immunochemical staining of the cultures shows that hepatocytes do not acquire or express the capacity to accumulate CPS at high rates synchronously. The average levels of CPS per hepatocyte that are observed upon hormone treatment are approx 50-fold lower in embryonic than in adult hepatocytes, corresponding with an approx 10-fold lower synthetic capacity (per gram hepatocytes) and an approx 5-fold smaller size of embryonic compared to adult hepatocytes. Carbamoylphosphate synthetase levels are therefore a good parameter in studies that aim to establish the mechanisms that underly the ontogenesis of the hepatic phenotype.
糖皮质激素和环磷酸腺苷可诱导大鼠肝细胞中的氨甲酰磷酸合成酶(CPS)。通过对原位固定的肝细胞培养物进行酶免疫测定,已证明一旦细胞可被识别为肝细胞,肝细胞在两种激素存在的情况下合成CPS的能力就已存在。培养物的免疫化学染色表明,肝细胞不会同步获得或表达以高速率积累CPS的能力。激素处理后观察到的每个肝细胞中CPS的平均水平,胚胎肝细胞比成年肝细胞低约50倍,这与(每克肝细胞)约低10倍的合成能力以及与成年肝细胞相比约小5倍的胚胎肝细胞大小相对应。因此,氨甲酰磷酸合成酶水平是旨在确定肝表型个体发生基础机制的研究中的一个良好参数。